Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02331134 · ClinicalTrials.gov registry record · NA
Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02331134 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 9 participants.
The verdict
NCT02331134, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The overall goal of this study is to develop a pre-clinical platform of melanoma and head and neck squamous cell cancer that will allow the investigators to learn more about these diseases and discover better and more individualized treatments.
Interventions
- DRUG Filgrastim
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-05-13 |
| Est. Completion | 2025-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02331134
The ClinicalTrials.gov registry entry for NCT02331134 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Filgrastim is the first listed.
NCT02331134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02331134 about?
NCT02331134 is a clinical study titled "Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer". The overall goal of this study is to develop a pre-clinical platform of melanoma and head and neck squamous cell cancer that will allow the investigators to learn more about these diseases and discover better and more individualized treatments.
What is the current status of trial NCT02331134?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2015-05-13. Estimated completion is 2025-03-06.
What interventions are being tested in trial NCT02331134?
The interventions under investigation include: Filgrastim (DRUG).
Who is sponsoring clinical trial NCT02331134?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.